Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 415,484 | 93,855 | 291,342 | 186,986 | 424,426 |
| Cost of Goods | 46,242 | 59,209 | 154,976 | 98,929 | 55,777 |
| Gross Profit | 369,242 | 34,646 | 136,366 | 88,057 | 368,649 |
| Operating Expenses | 208,486 | 179,686 | 320,910 | 214,618 | 313,969 |
| Operating Income | 160,998 | -144,831 | -183,568 | -125,632 | 55,457 |
| Interest Expense | 4,143 | 4,111 | 4,117 | 2,859 | 3,124 |
| Other Income | 7,731 | 3,654 | 10,984 | -2,982 | 5,532 |
| Pre-tax Income | 164,586 | -145,288 | -176,701 | -131,473 | 57,865 |
| Income Tax | 2,205 | 2,262 | 1,688 | -697 | -143 |
| Net Income Continuous | 162,381 | -147,550 | -178,389 | -130,776 | 58,008 |
| Net Income | $162,381 | $-147,550 | $-178,389 | $-130,776 | $58,008 |
| EPS Basic Total Ops | 1.09 | -1.05 | -1.39 | -1.26 | 0.65 |
| EPS Basic Continuous Ops | 1.09 | -1.05 | -1.38 | -1.26 | 0.65 |
| EPS Diluted Total Ops | 0.99 | -1.05 | -1.32 | -1.26 | 0.58 |
| EPS Diluted Continuous Ops | 0.98 | -1.05 | -1.29 | -1.26 | 0.56 |
| EPS Diluted Before Non-Recurring Items | 0.99 | -1.05 | -1.44 | N/A | N/A |
| EBITDA(a) | $172,130 | $-132,684 | $-172,774 | $-114,311 | $65,524 |